These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36039426)

  • 61. Collagen I promotes epithelial-to-mesenchymal transition in lung cancer cells via transforming growth factor-beta signaling.
    Shintani Y; Maeda M; Chaika N; Johnson KR; Wheelock MJ
    Am J Respir Cell Mol Biol; 2008 Jan; 38(1):95-104. PubMed ID: 17673689
    [TBL] [Abstract][Full Text] [Related]  

  • 62. CNTN-1 Enhances Chemoresistance in Human Lung Adenocarcinoma Through Induction of Epithelial-Mesenchymal Transition by Targeting the PI3K/Akt Pathway.
    Zhang R; Sun S; Ji F; Liu C; Lin H; Xie L; Yang H; Tang W; Zhou Y; Xu J; Li P
    Cell Physiol Biochem; 2017; 43(2):465-480. PubMed ID: 28934754
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Epicatechin-3-gallate reverses TGF-β1-induced epithelial-to-mesenchymal transition and inhibits cell invasion and protease activities in human lung cancer cells.
    Huang SF; Horng CT; Hsieh YS; Hsieh YH; Chu SC; Chen PN
    Food Chem Toxicol; 2016 Aug; 94():1-10. PubMed ID: 27224248
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Reprogramming during epithelial to mesenchymal transition under the control of TGFβ.
    Tan EJ; Olsson AK; Moustakas A
    Cell Adh Migr; 2015; 9(3):233-46. PubMed ID: 25482613
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Downregulation of tumor suppressing STF cDNA 3 promotes epithelial-mesenchymal transition and tumor metastasis of osteosarcoma by the Wnt/GSK-3β/β-catenin/Snail signaling pathway.
    Lv YF; Dai H; Yan GN; Meng G; Zhang X; Guo QN
    Cancer Lett; 2016 Apr; 373(2):164-73. PubMed ID: 26845447
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Podocalyxin influences malignant potential by controlling epithelial-mesenchymal transition in lung adenocarcinoma.
    Kusumoto H; Shintani Y; Kanzaki R; Kawamura T; Funaki S; Minami M; Nagatomo I; Morii E; Okumura M
    Cancer Sci; 2017 Mar; 108(3):528-535. PubMed ID: 28004467
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Blocking the epithelial-to-mesenchymal transition pathway abrogates resistance to anti-folate chemotherapy in lung cancer.
    Liang SQ; Marti TM; Dorn P; Froment L; Hall SR; Berezowska S; Kocher G; Schmid RA; Peng RW
    Cell Death Dis; 2015 Jul; 6(7):e1824. PubMed ID: 26181204
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The network of epithelial-mesenchymal transition: potential new targets for tumor resistance.
    Nantajit D; Lin D; Li JJ
    J Cancer Res Clin Oncol; 2015 Oct; 141(10):1697-713. PubMed ID: 25270087
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Overcoming epithelial-mesenchymal transition-mediated drug resistance with monensin-based combined therapy in non-small cell lung cancer.
    Ochi K; Suzawa K; Tomida S; Shien K; Takano J; Miyauchi S; Takeda T; Miura A; Araki K; Nakata K; Yamamoto H; Okazaki M; Sugimoto S; Shien T; Yamane M; Azuma K; Okamoto Y; Toyooka S
    Biochem Biophys Res Commun; 2020 Aug; 529(3):760-765. PubMed ID: 32736704
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Rubus idaeus L Inhibits Invasion Potential of Human A549 Lung Cancer Cells by Suppression Epithelial-to-Mesenchymal Transition and Akt Pathway In Vitro and Reduces Tumor Growth In Vivo.
    Chu SC; Hsieh YS; Hsu LS; Chen KS; Chiang CC; Chen PN
    Integr Cancer Ther; 2014 May; 13(3):259-73. PubMed ID: 24335666
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Novel Inhibitor for Downstream Targeting of Transforming Growth Factor-β Signaling to Suppress Epithelial to Mesenchymal Transition and Cell Migration.
    Toma T; Tateishi H; Kawakami K; Ali TFS; Kamo M; Monde K; Nakashima Y; Fujita M; Otsuka M
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563439
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Activation of histamine H4 receptors decreases epithelial-to-mesenchymal transition progress by inhibiting transforming growth factor-β1 signalling pathway in non-small cell lung cancer.
    Cai WK; Hu J; Li T; Meng JR; Ma X; Yin SJ; Zhao CH; He GH; Xu GL
    Eur J Cancer; 2014 Apr; 50(6):1195-206. PubMed ID: 24447834
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Benzophenone-3 increases metastasis potential in lung cancer cells via epithelial to mesenchymal transition.
    Phiboonchaiyanan PP; Busaranon K; Ninsontia C; Chanvorachote P
    Cell Biol Toxicol; 2017 Jun; 33(3):251-261. PubMed ID: 27796700
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The therapeutic potential of targeting the epithelial-mesenchymal transition in cancer.
    Ginnebaugh KR; Ahmad A; Sarkar FH
    Expert Opin Ther Targets; 2014 Jul; 18(7):731-45. PubMed ID: 24758643
    [TBL] [Abstract][Full Text] [Related]  

  • 75. CD44 Facilitates Epithelial-to-Mesenchymal Transition Phenotypic Change at Acquisition of Resistance to EGFR Kinase Inhibitors in Lung Cancer.
    Suda K; Murakami I; Yu H; Kim J; Tan AC; Mizuuchi H; Rozeboom L; Ellison K; Rivard CJ; Mitsudomi T; Hirsch FR
    Mol Cancer Ther; 2018 Oct; 17(10):2257-2265. PubMed ID: 30049789
    [TBL] [Abstract][Full Text] [Related]  

  • 76. PHD3 Controls Lung Cancer Metastasis and Resistance to EGFR Inhibitors through TGFα.
    Dopeso H; Jiao HK; Cuesta AM; Henze AT; Jurida L; Kracht M; Acker-Palmer A; Garvalov BK; Acker T
    Cancer Res; 2018 Apr; 78(7):1805-1819. PubMed ID: 29339541
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Daidzin targets epithelial-to-mesenchymal transition process by attenuating manganese superoxide dismutase expression and PI3K/Akt/mTOR activation in tumor cells.
    Yang MH; Jung SH; Um JY; Kumar AP; Sethi G; Ahn KS
    Life Sci; 2022 Apr; 295():120395. PubMed ID: 35181309
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The biological and clinical importance of epithelial-mesenchymal transition in circulating tumor cells.
    Liu H; Zhang X; Li J; Sun B; Qian H; Yin Z
    J Cancer Res Clin Oncol; 2015 Feb; 141(2):189-201. PubMed ID: 24965746
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Myeloid-derived suppressor cells promote lung cancer metastasis by CCL11 to activate ERK and AKT signaling and induce epithelial-mesenchymal transition in tumor cells.
    Lin S; Zhang X; Huang G; Cheng L; Lv J; Zheng D; Lin S; Wang S; Wu Q; Long Y; Li B; Wei W; Liu P; Pei D; Li Y; Wen Z; Cui S; Li P; Sun X; Wu Y; Yao Y
    Oncogene; 2021 Feb; 40(8):1476-1489. PubMed ID: 33452453
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Nobiletin inhibits epithelial-mesenchymal transition of human non-small cell lung cancer cells by antagonizing the TGF-β1/Smad3 signaling pathway.
    Da C; Liu Y; Zhan Y; Liu K; Wang R
    Oncol Rep; 2016 May; 35(5):2767-74. PubMed ID: 26986176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.